Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone

BACKGROUND: Optimal preoperative treatment before colorectal cancer metastases (CRCM) resection remains unclear. This study evaluated pathological responses (pR) in CRCM resected after chemotherapy alone or combined with angiogenesis or epidermal growth factor receptor (EGFR) inhibitors. METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrasco, J, Gizzi, M, Pairet, G, Lannoy, V, Lefesvre, P, Gigot, J-F, Hubert, C, Jouret-Mourin, A, Humblet, Y, Canon, J-L, Sempoux, C, Chapaux, X, Danse, E, Tinton, N, Navez, B, Van den Eynde, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815793/
https://www.ncbi.nlm.nih.gov/pubmed/26461062
http://dx.doi.org/10.1038/bjc.2015.321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815793/
https://www.ncbi.nlm.nih.gov/pubmed/26461062
http://dx.doi.org/10.1038/bjc.2015.321

Ejemplares similares